West Pharmaceutical Services (WST) Liabilities and Shareholders Equity (2009 - 2026)
West Pharmaceutical Services recorded quarterly Liabilities and Shareholders Equity of $4.1 billion in Q1 2026, down 3.75% quarter-over-quarter from $4.3 billion in Q4 2025, and up 13.59% year-over-year from $3.6 billion in Q1 2025.
West Pharmaceutical Services' Liabilities and Shareholders Equity history runs 18 years deep, the most recent figure standing at $4.1 billion for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity rose 13.59% year-over-year to $4.1 billion; the TTM figure through Mar 2026 stood at $16.4 billion (up 13.95% YoY), while the FY2025 annual figure was $4.3 billion, up 17.2% from the prior year.
- Liabilities and Shareholders Equity came in at $4.1 billion for Q1 2026 at West Pharmaceutical Services, down from $4.3 billion in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $4.3 billion in Q4 2025 to a low of $3.3 billion in Q1 2022.
- A 5-year average of $3.7 billion and a median of $3.7 billion in 2023 frame the typical range for Liabilities and Shareholders Equity.
- Across the five-year window, Liabilities and Shareholders Equity advanced 20.26% in 2022 and slipped 4.91% in 2024, its largest moves.
- West Pharmaceutical Services' Liabilities and Shareholders Equity stood at $3.6 billion in 2022, then grew by 5.88% to $3.8 billion in 2023, then dropped by 4.86% to $3.6 billion in 2024, then rose by 17.2% to $4.3 billion in 2025, then decreased by 3.75% to $4.1 billion in 2026.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $4.1 billion, $4.3 billion, and $4.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 20.11 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 50.83 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 8.78 Bn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 4.11 Bn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 14.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 12.42 Bn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 6.31 Bn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 19.85 Bn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 5.10 Bn |
| 10 | Repligen | 6.39 Bn | 5.41 Bn | 108.28 Mn | 2.93 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.11 Bn |
| Dec 31, 2025 | 4.27 Bn |
| Sep 30, 2025 | 4.11 Bn |
| Jun 30, 2025 | 3.95 Bn |
| Mar 31, 2025 | 3.62 Bn |
| Dec 31, 2024 | 3.64 Bn |
| Sep 30, 2024 | 3.68 Bn |
| Jun 30, 2024 | 3.49 Bn |
| Mar 31, 2024 | 3.60 Bn |
| Dec 31, 2023 | 3.83 Bn |
| Sep 30, 2023 | 3.75 Bn |
| Jun 30, 2023 | 3.67 Bn |
| Mar 31, 2023 | 3.72 Bn |
| Dec 31, 2022 | 3.62 Bn |
| Sep 30, 2022 | 3.32 Bn |
| Jun 30, 2022 | 3.36 Bn |
| Mar 31, 2022 | 3.29 Bn |
| Dec 31, 2021 | 3.31 Bn |
| Sep 30, 2021 | 3.14 Bn |
| Jun 30, 2021 | 2.93 Bn |
| Mar 31, 2021 | 2.74 Bn |
| Dec 31, 2020 | 2.79 Bn |
| Sep 30, 2020 | 2.58 Bn |
| Jun 30, 2020 | 2.39 Bn |
| Mar 31, 2020 | 2.25 Bn |
| Dec 31, 2019 | 2.34 Bn |
| Sep 30, 2019 | 2.17 Bn |
| Jun 30, 2019 | 2.12 Bn |
| Mar 31, 2019 | 2.04 Bn |
| Dec 31, 2018 | 1.98 Bn |
| Sep 30, 2018 | 1.95 Bn |
| Jun 30, 2018 | 1.87 Bn |
| Mar 31, 2018 | 1.87 Bn |
| Dec 31, 2017 | 1.86 Bn |
| Sep 30, 2017 | 1.93 Bn |
| Jun 30, 2017 | 1.84 Bn |
| Mar 31, 2017 | 1.73 Bn |
| Dec 31, 2016 | 1.72 Bn |
| Sep 30, 2016 | 1.74 Bn |
| Jun 30, 2016 | 1.71 Bn |
| Mar 31, 2016 | 1.67 Bn |
| Dec 31, 2015 | 1.70 Bn |
| Sep 30, 2015 | 1.67 Bn |
| Jun 30, 2015 | 1.66 Bn |
| Mar 31, 2015 | 1.60 Bn |
| Dec 31, 2014 | 1.67 Bn |
| Sep 30, 2014 | 1.67 Bn |
| Jun 30, 2014 | 1.70 Bn |
| Mar 31, 2014 | 1.71 Bn |
| Dec 31, 2013 | 1.67 Bn |
| Sep 30, 2013 | 1.66 Bn |
| Jun 30, 2013 | 1.61 Bn |
| Mar 31, 2013 | 1.58 Bn |
| Dec 31, 2012 | 1.56 Bn |
| Sep 30, 2012 | 1.53 Bn |
| Jun 30, 2012 | 1.46 Bn |
| Dec 31, 2011 | 1.40 Bn |
| Sep 30, 2011 | 1.40 Bn |
| Jun 30, 2011 | 1.42 Bn |
| Mar 31, 2011 | 1.37 Bn |
| Dec 31, 2010 | 1.29 Bn |
| Sep 30, 2010 | 1.30 Bn |
| Jun 30, 2010 | 1.22 Bn |
| Dec 31, 2009 | 1.27 Bn |